Industry Analysis & Industry Trends
The Veterinary Pharmaceutical Manufacturing industry is a relatively small segment of the general Australian pharmaceutical sector. The industry is involved in the development and manufacture of animal health products including veterinary medicines, vaccines, and other biological and medicinal feed additives. As such, it is geared towards two main segments: food-producing animals (including cattle, pigs, poultry and sheep) and companion animals (including cats and dogs). In 2012-13, the industry accounted for just 4.5% of the overall pharmaceutical sector.
Over the five years through 2014-15, the performance of the industry has been highly volatile, as it has contended with a number of external shocks... purchase to read more
Industry Report - Industry Investment Chapter
Like the rest of the pharmaceutical product manufacturing sector, this industry has a medium level of capital intensity. This reflects that capital is a core component in developing sophisticated veterinary pharmaceutical goods, with products often manufactured in costly production facilities using high-tech processes.
Simultaneously, the industry also relies heavily on the use of highly skilled labour to develop and manufacture its products. For every dollar spent on capital expenses, $7.89 is spent on labour. The skilled nature of the industry's labour force reflects its use of dangerous or toxic chemicals that could be fatal if incorrectly prepared... purchase to read more